Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.7.0 was added. A number of study document attachments were removed from the Study Documents section, including the Informed Consent Form (2019-12-04) and the Study Protocol/Statistical Analysis Plan PDFs.SummaryDifference18%

- Check40 days agoChange DetectedRevision: v3.6.6 appears on the page, updating from v3.6.5. This reflects a software or interface update to the study page rather than a modification to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor platform update to the page.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor software update to the page. This update does not modify study content or patient-facing information.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, signaling a new page version rather than a content change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.